Mingxue Zhou

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 3

Top Topics

Signaling Pathway

Top Venues

Evidence-based complementary and alternative medicine : eCAM

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Fuyong Chu, Xue Yan, Xingjiang Xiong, Mingxue Zhou, Yupei Tan, Yixuan Li, Wei Liu, Hongxu Liu
Traditional Chinese Medicine Shen-Yuan-Dan (SYD) Improves Hypoxia-Induced Cardiomyocyte Apoptosis in Neonatal Rats by Upregulating miR-24/Bim Pathway. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Sinai Li, Ping Li, Weihong Liu, Juju Shang, Shenglei Qiu, Xiang Li, Wei Liu, Haoyue Shi, Mingxue Zhou, Hongxu Liu
Danhong Injection Alleviates Cardiac Fibrosis via Preventing the Hypermethylation of Rasal1 and Rassf1 in TAC Mice. Oxidative medicine and cellular longevity 2020 (2020)
Ying Zhang, Pan Ren, Qunfu Kang, Weihong Liu, Sinai Li, Ping Li, Hongxu Liu, Juju Shang, Lei Zhang, Yanbing Gong, Mingxue Zhou
Effect of Tetramethylpyrazine on Atherosclerosis and SCAP/SREBP-1c Signaling Pathway in ApoE-/- Mice Fed with a High-Fat Diet. Evidence-based complementary and alternative medicine : eCAM 2017 (2017)